Form D · Biotechnology
TAUC3 Biologics Ltd
London, X0 · CIK 0001830913
Offering snapshot reported Mar 31, 2022 · SEC filing
- Reported sold
- $690K Offering amount: $690K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 24, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2022 | Initial | $690,000 | No comparison | 0 | SEC filing |
| Dec 28, 2020 | Initial | $18,700 | No comparison | 1 | SEC filing |
| Nov 20, 2020 | Initial | $11,000 | No comparison | 2 | SEC filing |
| Nov 3, 2020 | Initial | $148,500 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-439830
Source: Form D, filed Mar 31, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Chain | Director, Executive |
| John Gogol | Director |
| Andrew Heath | Director |
| Parag Saxena | Director |
| Shafique Virani | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5 New Street Square, Holborn
London, X0, EC4A 3TW
London, X0, EC4A 3TW